GGrantIndex
← Leaderboards

Angeline Sanderson Andrew

Dartmouth College

$3,224,164
Attributed
$4,199,164
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $590.8K · FY200520
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$2,899,164 · 9
ATSDR$1,300,000 · 2

By mechanism

R01$1,300,000 · 2
P42$903,771 · 1
K07$818,736 · 1
R21$762,307 · 2
R03$315,581 · 2
P20$98,769 · 3

Top collaborators

Most similar at Dartmouth College

Same institution · by research overlap

Others in their field

Top investigators on “Molecular

Research focus

MolecularArsenicExposure ToTumorRecording Of Previous EventsSmokingGeneticBladderVariantNew HampshireMortality Vital StatisticsIncidenceProgramsBaseMalignant Neoplasm Of Urinary BladderEpidemiologic StudiesSamplingDna RepairPrognosticInvestigationAffectLesionCancer PrognosisGrant

Grant awards (23)

Linking environmental contamination to residential history for risk identification$165,710
R21 · FY2020 · CA · contact PI
Linking environmental contamination to residential history for risk identification$209,012
R21 · FY2019 · CA · contact PI
Identify, Analyze, and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) - 2018$500,000
R01 · FY2018 · TS
A Population-Based Ohio ALS Repository and a Case-Control Study of ALS Risk Factors$400,000
R01 · FY2017 · TS
A Population-Based Ohio ALS Repository and a Case-Control Study of ALS Risk Factors$400,000
R01 · FY2016 · TS
MicroRNA dysregulation and bladder cancer prognosis$140,940
R21 · FY2015 · CA · contact PI
MicroRNA dysregulation and bladder cancer prognosis$246,645
R21 · FY2014 · CA · contact PI
Bladder Cancer Prognostic Indicators$144,180
K07 · FY2009 · CA · contact PI
Bladder Cancer Prognostic Indicators$104,710
K07 · FY2009 · CA · contact PI
Bladder Cancer Prognostic Indicators$144,180
K07 · FY2008 · CA · contact PI
EGFR PATHWAY ALTERATIONS IN LUNG TUMORS$21,361
P20 · FY2008 · RR · contact PI
Facility Core D: Biomarkers$346,555
P42 · FY2007 · ES · contact PI
Bladder Cancer Prognostic Indicators$144,180
K07 · FY2007 · CA · contact PI
Comprehensive Assessment of Bladder Cancer Genetic Susceptibility$77,631
R03 · FY2007 · CA · contact PI
EGFR PATHWAY ALTERATIONS IN LUNG TUMORS$22,444
P20 · FY2007 · RR · contact PI
Facility Core D: Biomarkers$282,869
P42 · FY2006 · ES · contact PI
Bladder Cancer Prognostic Indicators$142,639
K07 · FY2006 · CA · contact PI
Comprehensive Assessment of Bladder Cancer Genetic Susceptibility$79,950
R03 · FY2006 · CA · contact PI
EGFR PATHWAY ALTERATIONS IN LUNG TUMORS$54,964
P20 · FY2006 · RR · contact PI
Facility Core D: Biomarkers$274,347
P42 · FY2005 · ES
Bladder Cancer Prognostic Indicators$138,847
K07 · FY2005 · CA
DNA Repair and Bladder Cancer$79,000
R03 · FY2004 · CA
DNA Repair and Bladder Cancer$79,000
R03 · FY2003 · CA